The National Center for Oncological Hadrontherapy (CNAO) in Pavia, Italy, is a facility offering advanced therapy to fight cancer and one of only five centres in the world treating with both protons and carbon ions. Of the thousand patients treated so far, over 80% exhibit stability. In 2016, CNAO was the first centre in the world to treat eye melanoma patients with the active scanning system where the organ, and – in most cases – visual acuity, were preserved.

During 2017, CNAO (Pavia, Italy) treated 46% more patients than the previous year, for a total of 1600 patients since the first treatment. Clinical results are remarkable, showing 70% to 80% local control of tumours, across all pathologies. A crucial milestone was reached in March, when hadron therapy was included in the list of treatments provided by the national health service. CNAO also cooperates with CERN in the framework of the MEDICIS-Promed European Training Network, coordinated by CERN.

 

Find out more at http://fondazionecnao.it/en

 

 

Image credit: CNAO

Application Domain: 
Medtech

You are here